Ahmet Celik, Anil Sahin, Naim Ata, Inci Tugce Colluoglu, Dilek Ural, Emine Arzu Kanik, Mustafa Okan Ayvali, Mustafa Mahir Ulgu, Suayip Birinci, Mehmet Birhan Yilmaz
Major heart failure (HF) trials remain insufficient in terms of assessing the differences in clinical characteristics, biomarkers, treatment efficacy, and safety because of the under-representation of women. The study aimed to present sex-related disparities in HF management, including differences in demographics, co-morbidities, cardiac biomarkers, prescribed medications, and treatment outcomes. The study utilized anonymized data from the Turkish Ministry of Health's National Electronic Database between January 1, 2016, and December 31, 2022...
January 22, 2024: American Journal of Cardiology